» Articles » PMID: 23557404

Bioengineering Organized, Multilamellar Human Corneal Stromal Tissue by Growth Factor Supplementation on Highly Aligned Synthetic Substrates

Overview
Date 2013 Apr 6
PMID 23557404
Citations 49
Authors
Affiliations
Soon will be listed here.
Abstract

Recapitulating the microstructure of the native human corneal stromal tissue is believed to be a key feature in successfully engineering the corneal tissue. The stratified multilayered collagen fibril lamellae with orthogonal orientation determine the robust biomechanical properties of this tissue, and the uniform collagen fibril size and interfibrillar spacing are critical to its optical transparency. The objective of this investigation was to develop a highly organized collagen-fibril construct secreted by human corneal stromal stem cells (hCSSCs) to mimic the human corneal stromal tissue. In culture on a highly aligned fibrous substrate made from poly(ester urethane) urea, the fibroblast growth factor-2 (FGF-2, 10 ng/mL) and transforming growth factor-beta 3 (TGF-β3, 0.1 ng/mL) impacted the organization and abundance of the secreted collagen fibril matrix. hCSSCs differentiated into keratocytes with significant upregulation of the typical gene markers, including KERA, B3GnT7, and CHST6. FGF-2 treatment stimulated hCSSCs to secrete collagen fibrils strongly aligned in a single direction, whereas TGF-β3 induced collagenous layers with orthogonal fibril orientation. The combination of FGF-2 and TGF-β3 induced multilayered lamellae with orthogonally oriented collagen fibrils, in a pattern mimicking the human corneal stromal tissue. The constructs were 60-70 μm thick and had an increased content of cornea-specific extracellular matrix components, including keratan sulfate, lumican, and keratocan. The approach of combining substrate cues with growth factor augmentation offers a new means to engineer well-organized, collagen-based constructs with an appropriate nanoscale structure for corneal repair and regeneration.

Citing Articles

Focus on seed cells: stem cells in 3D bioprinting of corneal grafts.

Xie Z, Yuan B, Chi M, Hong J Front Bioeng Biotechnol. 2024; 12:1423864.

PMID: 39050685 PMC: 11267584. DOI: 10.3389/fbioe.2024.1423864.


Replace or Regenerate? Diverse Approaches to Biomaterials for Treating Corneal Lesions.

Bonato P, Bagno A Biomimetics (Basel). 2024; 9(4).

PMID: 38667213 PMC: 11047895. DOI: 10.3390/biomimetics9040202.


Increased Anti-Inflammatory Therapeutic Potential and Progenitor Marker Expression of Corneal Mesenchymal Stem Cells Cultured in an Optimized Propagation Medium.

Hopkinson A, Notara M, Cursiefen C, Sidney L Cell Transplant. 2024; 33:9636897241241992.

PMID: 38602231 PMC: 11010753. DOI: 10.1177/09636897241241992.


Good manufacturing practice production of human corneal limbus-derived stromal stem cells and in vitro quality screening for therapeutic inhibition of corneal scarring.

Santra M, Geary M, Rubin E, Hsu M, Funderburgh M, Chandran C Stem Cell Res Ther. 2024; 15(1):11.

PMID: 38185673 PMC: 10773078. DOI: 10.1186/s13287-023-03626-8.


Expansion and characterization of human limbus-derived stromal/mesenchymal stem cells in xeno-free medium for therapeutic applications.

Sahoo A, Damala M, Jaffet J, Prasad D, Basu S, Singh V Stem Cell Res Ther. 2023; 14(1):89.

PMID: 37061739 PMC: 10105964. DOI: 10.1186/s13287-023-03299-3.


References
1.
Lim M, Goldstein M, Tuli S, Schultz G . Growth factor, cytokine and protease interactions during corneal wound healing. Ocul Surf. 2006; 1(2):53-65. DOI: 10.1016/s1542-0124(12)70128-3. View

2.
Huh M, Kim Y, Park J, Bae S, Kim M, Chang Y . Distribution of TGF-beta isoforms and signaling intermediates in corneal fibrotic wound repair. J Cell Biochem. 2009; 108(2):476-88. DOI: 10.1002/jcb.22277. View

3.
Soo C, Beanes S, Hu F, Zhang X, Dang C, Chang G . Ontogenetic transition in fetal wound transforming growth factor-beta regulation correlates with collagen organization. Am J Pathol. 2003; 163(6):2459-76. PMC: 1892380. DOI: 10.1016/s0002-9440(10)63601-2. View

4.
Boivin W, Shackleford M, Vanden Hoek A, Zhao H, Hackett T, Knight D . Granzyme B cleaves decorin, biglycan and soluble betaglycan, releasing active transforming growth factor-β1. PLoS One. 2012; 7(3):e33163. PMC: 3316562. DOI: 10.1371/journal.pone.0033163. View

5.
Funderburgh J, Mann M, Funderburgh M . Keratocyte phenotype mediates proteoglycan structure: a role for fibroblasts in corneal fibrosis. J Biol Chem. 2003; 278(46):45629-37. PMC: 2877919. DOI: 10.1074/jbc.M303292200. View